[HTML][HTML] Consensus guidelines for the use and interpretation of angiogenesis assays

P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov… - Angiogenesis, 2018 - Springer
The formation of new blood vessels, or angiogenesis, is a complex process that plays
important roles in growth and development, tissue and organ regeneration, as well as …

New directions in therapeutic angiogenesis and arteriogenesis in peripheral arterial disease

BH Annex, JP Cooke - Circulation research, 2021 - Am Heart Assoc
The prevalence of peripheral arterial disease (PAD) in the United States exceeds 10 million
people, and PAD is a significant cause of morbidity and mortality across the globe. PAD is …

MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target

D Mellis, A Caporali - Biochemical Society Transactions, 2018 - portlandpress.com
MicroRNAs (miRNAs) are small non-coding RNAs of∼ 22 nucleotides, which have
increasingly been recognized as potent post-transcriptional regulators of gene expression …

[HTML][HTML] The role of circulating biomarkers in peripheral arterial disease

G Saenz-Pipaon, E Martinez-Aguilar, J Orbe… - International Journal of …, 2021 - mdpi.com
Peripheral arterial disease (PAD) of the lower extremities is a chronic illness predominantly
of atherosclerotic aetiology, associated to traditional cardiovascular (CV) risk factors. It is …

The multifactorial nature of microRNAs in vascular remodelling

SMJ Welten, EAC Goossens, PHA Quax… - Cardiovascular …, 2016 - academic.oup.com
Vascular remodelling is a multifactorial process that involves both adaptive and maladaptive
changes of the vessel wall through, among others, cell proliferation and migration, but also …

[HTML][HTML] Current status of angiogenic cell therapy and related strategies applied in critical limb ischemia

L Beltrán-Camacho, M Rojas-Torres… - International Journal of …, 2021 - mdpi.com
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease
(PAD), it is characterized by progressive blockade of arterial vessels, commonly correlated …

MicroRNAs and endothelial (Dys) function

G Santulli - Journal of cellular physiology, 2016 - Wiley Online Library
Accumulating evidence indicates that microRNAs (miRs)—non‐coding RNAs that can
regulate gene expression via translational repression and/or post‐transcriptional …

Regulation of angiogenesis by microRNAs in cardiovascular diseases

D Kir, E Schnettler, S Modi, S Ramakrishnan - Angiogenesis, 2018 - Springer
Non-coding RNAs are functional RNA molecules comprising the majority of human
transcriptome. Only about 1.5% of the human genome is transcribed into messenger RNAs …

[HTML][HTML] MicroRNA-411 and Its 5′-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia

RVCT van der Kwast, T Woudenberg, PHA Quax… - Molecular Therapy, 2020 - cell.com
MicroRNAs are posttranscriptional regulators of gene expression. As microRNAs can target
many genes simultaneously, microRNAs can regulate complex multifactorial processes …

Circulating extracellular vesicles in stroke patients treated with mesenchymal stem cells: a biomarker analysis of a randomized trial

OY Bang, EH Kim, YH Cho, MJ Oh, JW Chung… - Stroke, 2022 - Am Heart Assoc
Background: Mesenchymal stem cells (MSCs) secrete trophic factors and extracellular
vesicles (EVs). However, the level and role of EVs after MSC therapy in patients with stroke …